Vivmark Residential (NYSE: VMRK) holder to sell 1,602 shares

Rhea-AI Filing Summary

VIVMARK RESIDENTIAL (VMRK) received a notice that Robert A. Garechana intends, under Rule 144, to sell 1,602 shares of its common stock through JP Morgan Securities LLC on or about August 21, 2026 on the NYSE. The shares, with an aggregate market value of $105,091.20, were acquired via restricted stock vesting from the issuer as compensation on February 6, 2017. The filing reports 379,429,476 common shares outstanding.

Key Figures

Shares to be sold: 1,602 shares Aggregate market value: $105,091.20 Shares outstanding: 379,429,476 shares +2 more

5 metrics

Shares to be sold 1,602 shares Common stock proposed to be sold under Rule 144

Aggregate market value $105,091.20 Aggregate market value of the 1,602 shares to be sold

Shares outstanding 379,429,476 shares Common shares of VIVMARK RESIDENTIAL outstanding

Proposed sale date 08/21/2026 Approximate date of sale under Rule 144

Acquisition date 02/06/2017 Date the 1,602 shares vested as restricted stock compensation

Key Terms

Rule 144, restricted stock vesting, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 02/06/2017 | Restricted Stock Vesting | Issuer |"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"Common | JP Morgan Securities LLC ... | 1602 | 105091.20 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing for VMRK disclose?

It discloses that Robert A. Garechana plans to sell 1,602 shares of VIVMARK RESIDENTIAL common stock under Rule 144, with an aggregate market value of $105,091.20, through JP Morgan Securities LLC on or about August 21, 2026 on the NYSE.

How many VMRK shares are planned to be sold under this Form 144?

The notice states an intention to sell 1,602 shares of VIVMARK RESIDENTIAL common stock. These shares were previously acquired via restricted stock vesting as compensation on February 6, 2017.

What is the aggregate market value of the VMRK shares in this Form 144?

The filing reports an aggregate market value of $105,091.20 for the 1,602 shares of VIVMARK RESIDENTIAL common stock proposed to be sold under Rule 144.

How many VMRK shares are outstanding according to this Form 144?

The Form 144 indicates that there are 379,429,476 shares of VIVMARK RESIDENTIAL common stock outstanding at the time of the notice. This figure is a baseline for context and is not the amount being sold.

When and how were the VMRK shares in this Form 144 acquired?

The 1,602 shares covered by the Form 144 were acquired on February 6, 2017 through restricted stock vesting from the issuer, VIVMARK RESIDENTIAL, as compensation.

Which broker is named in the VMRK Form 144 filing?

The Form 144 lists JP Morgan Securities LLC as the broker for the planned sale of 1,602 shares of VIVMARK RESIDENTIAL common stock, expected to be sold on the NYSE on or about August 21, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 05:42 PM Accepted by SEC EDGAR 08/24/2026 - 05:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001750568
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VIVMARK RESIDENTIAL
SEC File Number	001-12252
Address of Issuer	VIVMARK RESIDENTIAL TWO NORTH RIVERSIDE PLAZA, SUITE 400 CHICAGO ILLINOIS 60606
Phone	3124741300
Name of Person for Whose Account the Securities are To Be Sold	Garechana Robert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	JP Morgan Securities LLC 277 Park Avenue New York NY 10172	1602	105091.20	379429476	08/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/06/2017	Restricted Stock Vesting	Issuer			1602	02/06/2017	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Robert A Garechana
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)